Why Understanding GLP-1 Science Matters for Your Weight Management Many weight loss failures stem from fighting your body's natural hunger machinery rather than optimizing it
Do GLP-1 drugs help with fatty liver
Our experience testing Henry Meds semaglutide While we dont always have testers who are willing or even appropriate candidates to try certain prescription medications, we were able to try semaglutide from Henry, specifically its sublingual oral drops
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Retatrutide is an investigational 39-amino-acid, fatty-acid-acylated triple agonist engineered to engage the GIP, GLP-1, and glucagon receptors from a single peptide backbone
